|
1.
|
MK SheaSL BoothUpdate on the role of
vitamin K in skeletal healthNutr
Rev66549557200810.1111/j.1753-4887.2008.00106.x18826451
|
|
2.
|
M YamaguchiMN WeitzmannQuercetin, a potent
suppressor of NF-κB and Smad activation in osteoblastsInt J Mol
Med28521525201121769418
|
|
3.
|
M YamaguchiMN WeitzmannZinc stimulates
osteoblastogenesis and suppresses osteoclastogenesis by
antagonizing NF-kappaB activationMol Cell
Biochem355179186201110.1007/s11010-011-0852-z21533765
|
|
4.
|
M YamaguchiMN WeitzmannVitamin
K2 stimulates osteoblastogenesis and suppresses
osteoclastogenesis by suppressing NF-κB activationInt J Mol
Med273142011
|
|
5.
|
M YamaguchiJL ArbiserMN WeitzmannHonokiol
stimulates osteoblastogenesis by suppressing NF-κB activationInt J
Mol Med2810491053201121887456
|
|
6.
|
M YamaguchiMN WeitzmannThe bone anabolic
carotenoids p-hydroxycinnamic acid and β-cryptoxanthin
antagonize NF-κB activation in MC3T3 preosteoblastsMol Med
Rep26416442009
|
|
7.
|
M YamaguchiMN WeitzmannThe bone anabolic
carotenoid β-cryptoxanthin enhances transforming growth
factor-β1-induced Smad activation in MC3T3 preosteoblastsInt J Mol
Med246716752009
|
|
8.
|
S VairaM AlhawagriI AnwisyeH KitauraR
FaccioDV NovackRelA/p65 promotes osteoclast differentiation by
blocking a RANKL-induced apoptotic JNK pathway in miceJ Clin
Invest11820882097200818464930
|
|
9.
|
BF BoyceL XingG FranzosoU
SiebenlistRequired and nonessential functions of nuclear
factor-kappaB in bone
cellsBone25137139199910.1016/S8756-3282(99)00105-210423039
|
|
10.
|
K StraitY LiDL DillehayMN
WeitzmannSuppression of NF-κB activation blocks osteoclastic bone
resorption during estrogen deficiencyInt J Mol Med215215252008
|
|
11.
|
S DaiT HirayamaS AbbasY Abu-AmerThe
IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks
osteoclastogenesis and bone erosion in inflammatory arthritisJ Biol
Chem2793721937222200410.1074/jbc.C40025820015252035
|
|
12.
|
R FengG AndersonG XiaoSDX-308, a
nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity,
resulting in strong inhibition of osteoclast formation/activity and
multiple myeloma cell
growthBlood10921302138200710.1182/blood-2006-07-02745817095620
|
|
13.
|
MS NanesTumor necrosis factor-alpha:
molecular and cellular mechanisms in skeletal
pathologyGene321115200310.1016/S0378-1119(03)00841-214636987
|
|
14.
|
Y LiA LiK StraitH ZhangMS NanesMN
WeitzmannEndogenous TNFalpha lowers maximum peak bone mass and
inhibits osteoblastic Smad activation, through NF-kappaBJ Bone
Miner Res22646655200710.1359/jbmr.07012117266397
|
|
15.
|
EC WahlJ AronsonL LiuRestoration of
regenerative osteoblastogenesis in aged mice: modulation of TNFJ
Bone Miner Res25114123201010.1359/jbmr.09070819580462
|
|
16.
|
EC WahlJ AronsonL LiuDirect bone formation
during distraction osteogenesis does not require TNFalpha receptors
and elevated serum TNFalpha fails to inhibit bone formation in
TNFR1 deficient miceBone46410417201010.1016/j.bone.2009.09.011
|
|
17.
|
J ChangZ WangE TangInhibition of
osteoblastic bone formation by nuclear factor-kappaBNat
Med15682689200910.1038/nm.195419448637
|
|
18.
|
M YamazakiH FukushimaM ShinTumor necrosis
factor alpha represses bone morphogenetic protein (BMP) signaling
by interfering with the DNA binding of Smads through the activation
of NF-kappaBJ Biol
Chem2843598735995200910.1074/jbc.M109.07054019854828
|
|
19.
|
R GuoM YamashitaQ ZhangUbiquitin ligase
Smurf1 mediates tumor necrosis factor-induced systemic bone loss by
promoting proteasomal degradation of bone morphogenetic signaling
proteinsJ Biol
Chem2832308423092200810.1074/jbc.M70984820018567580
|
|
20.
|
RA EliseevEM SchwarzMJ ZuscikRJ O’KeefeH
DrissiRN RosierSmad7 mediates inhibition of Saos2 osteosarcoma cell
differentiation by NFkappaBExp Cell
Res3124050200610.1016/j.yexcr.2005.09.01616259979
|
|
21.
|
YL LaiM YamaguchiPhytocomponent
p-hydroxycinnamic acid stimulates bone formation and
inhibits bone resorption in rat femoral tissues in vitroMol Cell
Biochem2924552200617036165
|
|
22.
|
YL LaiM YamaguchiPhytocomponent
p-hydroxycinnamic acid inhibits osteoclast-like cell
formation in mouse bone marrow culturesInt J Mol
Med191231282007
|
|
23.
|
M YamaguchiYL LaiS UchiyamaT NakagawaOral
administration of phytocomponent p-hydroxycinnamic acid
prevents bone loss in ovariectomized ratsMol Cell
Biochem31131362008
|
|
24.
|
M YamaguchiS UchiyamaYL LaiOral
administration of phytocomponent p-hydroxycinnamic acid has
a preventive effect on bone loss in streptozotocin-induced diabetic
ratsInt J Mol Med198038072007
|
|
25.
|
E SugimotoM YamaguchiAnabolic effect of
genistein in osteoblastic MC3T3-E1 cellsInt J Mol
Med5515520200010762655
|
|
26.
|
MD AbramoffPJ MagelhaesSJ RamImage
processing with ImageJBiophotonics Int1136422004
|
|
27.
|
MN WeitzmannR PacificiEstrogen deficiency
and bone loss: an inflammatory taleJ Clin
Invest11611861194200610.1172/JCI2855016670759
|
|
28.
|
S CenciMN WeitzmannC RoggiaEstrogen
deficiency induces bone loss by enhancing T-cell production of
TNF-alphaJ Clin Invest10612291237200010.1172/JCI1106611086024
|
|
29.
|
J LamS TakeshitaJE BarkerO KanagawaFP
RossSL TeitelbaumTNF-alpha induces osteoclastogenesis by direct
stimulation of macrophages exposed to permissive levels of RANK
ligandJ Clin Invest10614811488200010.1172/JCI1117611120755
|
|
30.
|
YH ZhangA HeulsmannMM TondraviA MukherjeeY
Abu-AmerTumor necrosis factor-alpha (TNF) stimulates RANKL-induced
osteoclastogenesis via coupling of TNF type 1 receptor and RANK
signaling pathwaysJ Biol
Chem276563568200110.1074/jbc.M008198200
|
|
31.
|
K FullerC MurphyB KirsteinSW FoxTJ
ChambersTNFalpha potently activates osteoclasts, through a direct
action independent of and strongly synergistic with
RANKLEndocrinology14311081118200211861538
|
